PRISYM ID Announces Six Further Projects go Live as Medical Device and Life Science Organizations Prepare for the Future

  • Labeling software firm has implemented six new software systems in the last few months in a sign that the market is now rebalancing after the upheavals of the last 12 months.
  • It says customers within the medical device and life science sectors are increasingly demanding agile, industry-specific solutions that can be implemented within months as they race to make up for the lost time.

Wokingham, United Kingdom — 25 May 2021 — Following its announcement of five significant business wins at the start of the year, PRISYM ID has said that it has successfully implemented a further six new regulated labeling software systems as demand from across the medical device and life science sectors increases.

The market-leading labeling software firm says that this strong performance demonstrates the medical device and life science industries are recovering from the impact of the pandemic and are refocusing on implementing labeling management solutions to help prepare for the future.

The company adds that it sees the experience of the pandemic having an impact on the market as customers look for solutions that will increase their flexibility and allow them to respond more effectively to any change or uncertainty in their business over the months ahead.

In particular, many organizations are prioritizing speed of implementation as they seek to implement solutions that can help them as they prepare for life post-pandemic – as a result, PRISYM ID says that its customers are putting a far greater focus on so-called “time to value” for their technology investments than ever before.

Richard Adams, Chief Executive of PRISYM ID, said: “We are incredibly pleased to have delivered PRISYM 360 solutions across both our medical device and clinical trial supply sectors. The first few months of 2021 have been extremely busy for us as it is clear that the legacy of COVID-19 has focused people’s minds.

“For our customers, fast and agile implementation combined with specialist industry knowledge are extremely important, and the projects we have successfully executed in recent months show we can deliver the best of all worlds: high-quality solutions, delivered at speed, by genuine experts in the field.”


PRISYM ID provides regulated content and label management solutions designed specifically for life science companies and medical device manufacturers, improving patient safety and health outcomes whilst ensuring regulatory compliance. PRISYM ID’s unique products and technologies are used to assure compliance globally, for 10 million+ medical device, clinical trial and pharmaceutical products annually.